Evidence map›Paper›PMID 34805797›Full record

ArticleiScience2021

Naofumi Yoshida, Tomoya Yamashita, Tatsunori Osone, Tetsuya Hosooka, Masakazu Shinohara, Seiichi Kitahama, Kengo Sasaki, Daisuke Sasaki, Takeshi Yoneshiro, Tomohiro Suzuki and 14 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 127 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. ACS central science · 2026
    Article
  6. Article
  7. [Gut microbiota-associated metabolites with drug-induced liver injury].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  8. Article
  9. Review
  10. The Japanese gut microbiome: ecology, uniqueness, and impact on health and disease.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2026
    Review
  11. Article
  12. Exploring the interplay betweenThe veterinary quarterly · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Polyphenol-Rich Extract ofPlants (Basel, Switzerland) · 2025
    Article
  18. Article
  19. Apple Juice Fermented withFoods (Basel, Switzerland) · 2025
    Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 12 institutions in 2 countries.

Naofumi YoshidaDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 6500017, Japan.
Tomoya YamashitaDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 6500017, Japan.
Tatsunori OsoneSchool and Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Tokyo 1528550, Japan.
Tetsuya HosookaLaboratory of Nutritional Physiology, School of Food and Nutritional Sciences/Graduate Division of Nutritional and Environmental Sciences, University of Shizuoka, Shizuoka 4228526, Japan.
Masakazu ShinoharaDivision of Epidemiology, Kobe University Graduate School of Medicine, Kobe 6500017, Japan.
Seiichi KitahamaDepartment of Metabolic and Bariatric Surgery, Center for Obesity, Diabetes and Endocrinology, Chibune General Hospital, Osaka 5550034, Japan.
Kengo SasakiGraduate School of Science, Technology and Innovation, Kobe University, Kobe 6578501, Japan.
Daisuke SasakiGraduate School of Science, Technology and Innovation, Kobe University, Kobe 6578501, Japan.
Takeshi YoneshiroDivision of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo 1538904, Japan.
Tomohiro SuzukiLaboratory of Epigenetics and Metabolism, Institute for Molecular and Cellular Regulation, Gunma University, Gunma 3718512, Japan.
Takuo EmotoDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 6500017, Japan.
Yoshihiro SaitoDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 6500017, Japan.
Genki OzawaTechnoSuruga Laboratory Co., Ltd., Shizuoka 4240065, Japan.
Yushi HirotaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 6500017, Japan.
Yasuyuki KitauraLaboratory of Nutritional Biochemistry, Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 4648601, Japan.
Yoshiharu ShimomuraDepartment of Food and Nutritional Sciences, College of Bioscience and Biotechnology, Chubu University, Kasugai, Aichi 4878501, Japan.
Yuko Okamatsu-OguraFaculty of Veterinary Medicine, Hokkaido University, Sapporo 0600818, Japan.
Masayuki SaitoFaculty of Veterinary Medicine, Hokkaido University, Sapporo 0600818, Japan.
Akihiko KondoGraduate School of Science, Technology and Innovation, Kobe University, Kobe 6578501, Japan.
Shingo KajimuraDivision of Endocrinology, Diabetes & Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Takeshi InagakiLaboratory of Epigenetics and Metabolism, Institute for Molecular and Cellular Regulation, Gunma University, Gunma 3718512, Japan.
Wataru OgawaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 6500017, Japan.
Takuji YamadaSchool and Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Tokyo 1528550, Japan.
Ken-Ichi HirataDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 6500017, Japan.
Kobe University · JPGunma University · JPHokkaido University · JPTokyo Institute of Technology · JPBeth Israel Deaconess Medical Center · USChibune General Hospital · JPChubu University · JPJapan Agency for Medical Research and Development · JPNagoya University · JPOkayama Prefecture · JPThe University of Tokyo · JPUniversity of Shizuoka · JP

Funding

Mitochondrial Metabolite Compartmentalization in Health and DiseaseDP1DK126160 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KAJIMURA, SHINGO · 2020 to 2025
$4.4M
Mitochondrial BCAA transporter in physiology and diseaseR01DK125283 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KAJIMURA, SHINGO · 2021 to 2025
$1.8M
NIDDK NIH HHS DP1 DK126160NIDDK NIH HHS R01 DK125283
6 · The paper itself

Abstract

The gut microbiome has emerged as a key regulator of obesity; however, its role in brown adipose tissue (BAT) metabolism and association with obesity remain to be elucidated. We found that the levels of circulating branched-chain amino acids (BCAA) and their cognate α-ketoacids (BCKA) were significantly correlated with the body weight in humans and mice and that BCAA catabolic defects in BAT were associated with obesity in diet-induced obesity (DIO) mice. Pharmacological systemic enhancement of BCAA catabolic activity reduced plasma BCAA and BCKA levels and protected against obesity; these effects were reduced in BATectomized mice. DIO mice gavaged with

Indexed as

Computer systems organizationEnergy engineeringEnergy systems

Identifiers

PMID34805797
PMCPMC8586802
OpenAlexW3208168067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.